# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001628280-24-025800
Filing Date
2024-05-30
Accepted
2024-05-30 16:14:21
Documents
22
Period of Report
2024-05-28
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | mrk-20240528.htm iXBRL | 8-K | 82403
2 | EX-4.1 | exhibit41-8xk.htm | EX-4.1 | 545627
3 | EX-4.2 | exhibit42-8xk.htm | EX-4.2 | 139090
4 | EX-4.3 | exhibit43-8xk.htm | EX-4.3 | 134475
5 | EX-4.4 | exhibit44-8xk.htm | EX-4.4 | 131468
6 | EX-4.5 | exhibit45-8xk.htm | EX-4.5 | 137414
7 | EX-5.1 | exhibit51-8xk.htm | EX-5.1 | 14705
8 | EX-5.2 | exhibit52-8xk.htm | EX-5.2 | 65583
13 |  | lllogo.jpg | GRAPHIC | 260497
| Complete submission text file | 0001628280-24-025800.txt |  | 1998636

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
9 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | mrk-20240528.xsd | EX-101.SCH | 3322
10 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | mrk-20240528_def.xml | EX-101.DEF | 17185
11 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | mrk-20240528_lab.xml | EX-101.LAB | 30664
12 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | mrk-20240528_pre.xml | EX-101.PRE | 18043
25 | EXTRACTED XBRL INSTANCE DOCUMENT | mrk-20240528_htm.xml | XML | 6179

Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 908-740-4000
Merck & Co., Inc. (Filer) CIK: 0000310158 (see all company filings)

EIN.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-06571 | Film No.: 241005555
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)